Search

everythinglearnresearchcommunity

for

Search:↓

Exosomes from fat-derived stem cells can potentially improve hair growth and could be a new treatment for immune-related hair loss.

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

More people are seeing dermatologists for hair and scalp problems now than in the past.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Combining CGF and microneedling with betamethasone effectively treats resistant alopecia areata.

Non-drug therapies show promise for hair regrowth but need more research.

Several treatments are effective for pigmentary disorders like vitiligo and melasma.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

Wigs help improve self-esteem and quality of life for people with hair loss from alopecia areata.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Activated PRP injections are effective in treating hair loss and improving hair density.

Platelet-rich plasma therapy is a safe and effective treatment for alopecia areata.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.